These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 3493866)
1. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia. Agnello V; Mitamura T Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866 [TBL] [Abstract][Full Text] [Related]
2. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Antes U; Heinz HP; Loos M Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749 [TBL] [Abstract][Full Text] [Related]
3. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system. Antes U; Heinz HP; Loos M J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573 [TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay. Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507 [TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893 [TBL] [Abstract][Full Text] [Related]
6. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis. Roberts JL; Wyatt RJ; Schwartz MM; Lewis EJ Clin Immunol Immunopathol; 1983 Nov; 29(2):223-41. PubMed ID: 6605223 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of circulating immune complexes in lupus nephritis by solid phase C1q and conglutinin binding assays. Yoshida H; Muso E; Inoue S; Furukawa F; Sekita K; Kawai C; Hamashima Y Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):293-300. PubMed ID: 6611433 [No Abstract] [Full Text] [Related]
8. [Autoantibodies against the complement component C1q in systemic lupus erythematosus]. Antes U; Heinz HP; Hartung K; Loos M Klin Wochenschr; 1990 Nov; 68(21):1066-70. PubMed ID: 2084321 [TBL] [Abstract][Full Text] [Related]
9. C1q and immune complexes in liver cirrhosis sera. Yoshida H; Sato M; Watanabe S; Nishimaki T; Morito T; Kasukawa R; Nakai M Tohoku J Exp Med; 1983 May; 140(1):73-9. PubMed ID: 6603034 [TBL] [Abstract][Full Text] [Related]
10. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease. Greisman SG; Redecha PB; Kimberly RP; Christian CL J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531 [TBL] [Abstract][Full Text] [Related]
11. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus. Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589 [TBL] [Abstract][Full Text] [Related]
12. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. Uwatoko S; Mannik M J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124 [TBL] [Abstract][Full Text] [Related]
13. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus. Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256 [TBL] [Abstract][Full Text] [Related]
14. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA. Larsson A; Sjöquist J J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142 [TBL] [Abstract][Full Text] [Related]
15. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. Siegert C; Daha M; Westedt ML; van der Voort E; Breedveld F J Rheumatol; 1991 Feb; 18(2):230-4. PubMed ID: 2023216 [TBL] [Abstract][Full Text] [Related]
16. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus. Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422 [TBL] [Abstract][Full Text] [Related]
17. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K Clin Immunol Immunopathol; 1984 Jan; 30(1):104-16. PubMed ID: 6421520 [TBL] [Abstract][Full Text] [Related]
18. Evidence for detection of low molecular weight DNA--anti-DNA complexes in systemic lupus erythematosus. Agnello V; Mitamura T Arthritis Rheum; 1982 Jul; 25(7):788-92. PubMed ID: 7049182 [No Abstract] [Full Text] [Related]
19. Complement components, complement activation, and acute phase response in systemic lupus erythematosus. Sturfelt G; Sjöholm AG Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533 [TBL] [Abstract][Full Text] [Related]